0
Obstructive Lung Diseases: Safety and Effectiveness of COPD Treatments |

Long Acting Nebulized Agents Decrease Readmissions in Patients With Suboptimal Peak Inspiratory Flow

Chee Hong Loh, MD; Tina Lovings, RCP; Jill Ohar, MD
Author and Funding Information

Wake Forest Baptist Medical Center, Winston Salem, NC


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):925A. doi:10.1016/j.chest.2016.08.1025
Text Size: A A A
Published online

Extract

SESSION TITLE: Safety and Effectiveness of COPD Treatments

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Tuesday, October 25, 2016 at 11:00 AM - 12:15 PM

PURPOSE: Chronic obstructive pulmonary disease (COPD) has a significant socioeconomic burden. After hospitalization for an exacerbation of COPD, readmission rates are >20%. Patients with COPD are commonly discharged on dry power inhalers (DPI) after being admitted for COPD exacerbation. DPIs require an initial fast inhalation to break up pellets into particles that can be deposited deep into the respiratory tract. However, 20% of patients with advanced COPD did not reach the recommended peak inspiratory flow rate (PIF) for DPI devices. Patients with suboptimal PIF have fewer days to all cause and COPD readmissions. Our aim is to determine the benefit of nebulized therapies instead of DPI for patients with suboptimal PIF.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543